{"doi":"10.36922/msam.1705","title":"Fatigue behavior of additively manufactured Ti3Al2V alloy","abstract":"This study measured the tensile, compression, and fatigue behavior of additively manufactured Ti3Al2V as a function of build orientation. Ti3Al2V alloy was prepared by mixing commercially pure titanium (CpTi) and Ti6Al4V in 1:1 wt. ratio. Laser powder bed fusion (L-PBF) based additive manufacturing (AM) technique was used to fabricate the samples. Tensile tests resulted in an ultimate strength of 989 ± 8 MPa for Ti3Al2V. Ti6Al4V 90° orientation samples showed a compressive yield strength of 1178 ± 33 MPa, and that for Ti3Al2V 90° orientation was 968 ± 24 MPa. Varying the build orientation to account for anisotropy, Ti32-45° and Ti32-0° displayed similar compressive yield strength values of 1071 ± 16 and 1051± 18 MPa, respectively, higher than Ti32-90°. Fatigue loading revealed an endurance limit (10 million cycles) of 250 MPa for Ti6Al4V and 219 MPa for Ti3Al2V built at 90° orientations. The effect of the build orientation was significant under fatigue loading; Ti3Al2V built at 45° displayed an endurance limit of 387.5 MPa, and 0° showed 512 MPa; more than two-fold increment in endurance limit was observed. Our results show the potential of Ti3Al2V alloy for orthopedic devices, replacing Ti6Al4V alloy, particularly in load-bearing applications.","journal":"Materials Science in Additive Manufacturing","year":2023,"id":340223,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":16,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9542,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1029564,"name":"Sushant Ciliveri","orcid":"0000-0002-9036-4806","position":1,"is_corresponding":false},{"id":1075242,"name":"Stefano Guariento","orcid":null,"position":2,"is_corresponding":false},{"id":1075243,"name":"Nathan Zuckschwerdt","orcid":null,"position":3,"is_corresponding":false},{"id":1075244,"name":"William W Hogg","orcid":null,"position":4,"is_corresponding":false},{"id":492065,"name":"Amit Bandyopadhyay","orcid":"0000-0003-0992-5387","position":0,"is_corresponding":true}],"reference_count":17,"raw_metadata":null,"created_at":"2026-07-19T01:10:54.145367Z","pmid":"38174053","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}